DDC Enterprise Limited Reports on NYSE American Noncompliance Notice
DDC Enterprise (NYSE American: DDC) announced it received a noncompliance notice from NYSE Regulation on May 16, 2024. The company failed to timely file its Annual Report on Form 20-F for the fiscal year ended December 31, 2023, which was due on May 15, 2024. According to Section 1007 of the NYSE American Company Guide, DDC has six months to submit the required filing to regain compliance. If it fails to do so, an additional six-month cure period may be granted. Failure to comply could lead to suspension and delisting. The NYSE Notice does not affect DDC's business operations or SEC reporting obligations. DDC's shares continue to trade on the NYSE American.
- DDC has a six-month initial cure period to file the overdue Form 20-F.
- The company’s Class A Ordinary Shares will continue to be listed on NYSE American during the cure period.
- The NYSE Notice does not impact the company’s business operations or reporting obligations under SEC regulations.
- DDC missed the deadline to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2023.
- Failure to file within the initial six-month cure period may lead to suspension and delisting procedures.
- There is no assurance that DDC will regain compliance with NYSE American's listing standards.
- The delay in completing financial statements indicates potential issues in financial management or reporting.
Notice of Noncompliance: The receipt of the NYSE American noncompliance notice due to the delayed filing of the 2023 Form 20-F is a significant issue for DDC Enterprise Limited. This reflects the company's struggle with timely financial reporting, which might indicate underlying administrative or operational difficulties. Failing to meet filing deadlines can erode investor confidence and lead to potential delisting if the problem persists.
Short-term Impact: In the short term, this notice can cause volatility in the company's stock price as investors react to the uncertainty. The company has six months to address this issue; however, the risk of potential delisting will weigh heavily on investor sentiment until compliance is restored.
Long-term Concerns: For the long-term, consistent noncompliance can have severe implications, including loss of institutional investor support, difficulties in raising capital and deteriorating market reputation. Investors should be wary of prolonged issues in financial reporting as it typically reflects deeper issues within the company.
Key Data: The company has six months to cure the filing delinquency, with a possible extension of another six months. Therefore, it's critical to monitor the company's actions closely until compliance is regained.
Industry Context: Regulatory compliance is a cornerstone of investor trust, especially for companies listed on major exchanges like NYSE American. The failure to timely file financial reports is often seen as a red flag, not only by investors but also by potential business partners and clients. This can impact the company's ability to secure new contracts and negotiate favorable terms.
Investor Sentiment: Delay in financial reporting can lead to speculation and negative sentiment among retail investors. It’s important for the company to provide clear communication and transparency about the cause of the delay and the steps being taken to resolve it.
Strategic Considerations: DDC Enterprise Limited should focus on ensuring robust internal controls and processes to avoid such lapses in the future. Strengthening the finance team and improving reporting mechanisms can be vital steps in regaining investor trust and ensuring long-term stability.
NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- DDC ENTERPRISE LIMITED (NYSE AMERICAN: DDC) (“DAYDAYCOOK” OR THE “COMPANY”) announced today that on May 16, 2024, the Company received a written notice from NYSE Regulation (the “NYSE Notice”) stating that the Company is not in compliance with the continued listing standards of the NYSE American LLC (“NYSE American”, or the “Exchange”) under the timely filing criteria included in Section 1007 of the NYSE American Company Guide (the “Company Guide”) because the Company failed to timely file with the Securities and Exchange Commission (the “SEC”) its Annual Report on Form 20-F for the fiscal year ended December 31, 2023 (the “2023 Form 20-F”), which was due on May 15, 2024 (the “Filing Delinquency”).
In accordance with Section 1007 of the Company Guide, the Company will have six months from the date of the Filing Delinquency (the “Initial Cure Period”), to file the 2023 Form 20-F with the SEC. The Exchange will monitor the Company and the status of the 2023 Form 20-F and any subsequent delayed filings, including through contact with the Company, until the Filing Delinquency is cured. If the Company fails to file the 2023 Form 20-F during the Initial Cure Period, the Exchange may, in its sole discretion, grant an up to six-month additional cure period (the “Additional Cure Period”). The Company can regain compliance with the Exchange’s continued listing standards at any time during the Initial Cure Period or Additional Cure Period, as applicable, by filing the 2023 Form 20-F and any subsequent delayed filings with the SEC. If the Exchange determines that an Additional Cure Period is not appropriate, suspension and delisting procedures will commence in accordance with the procedures set out in Section 1010 of the Company Guide. If the Exchange determines that an Additional Cure Period is appropriate and the Company fails to file the 2023 Form 20-F and any subsequent delayed filings by the end of that period, suspension and delisting procedures will generally commence.
Notwithstanding the foregoing, however, the Exchange may, in its sole discretion, decide (i) not to afford the Company any Initial Cure Period or Additional Cure Period, as the case may be, at all or (ii) at any time during the Initial Cure Period or Additional Cure Period, to truncate the Initial Cure Period or Additional Cure Period, as the case may be, and immediately commence suspension and delisting procedures if the Company is subject to delisting pursuant to any other provision of the Company Guide, including if the Exchange believes, in the its sole discretion, that continued listing and trading of the Company’s securities on the Exchange is inadvisable or unwarranted in accordance with Sections 1001 through 1006 thereof.
As disclosed in the Form 12b-25 filed by the Company with the SEC on April 30, 2024, the Company was unable, without unreasonable effort or expense, to file its 2023 Form 20-F as a result of a delay experienced by the Company in completing its financial statements in the Annual Report. The Company was not able to file the 2023 Form 20-F within the fifteen-day extension period granted pursuant to Rule 12b-25 under the Securities Exchange Act of 1934, as amended. The Company is making all efforts to file the 2023 Form 20-F as soon as possible and in any event within the six-month Initial Cure Period. However, there can be no assurance that the Company will ultimately regain compliance with all applicable Exchange listing standards.
In the interim, the Company’s Class A Ordinary Shares will continue to be listed on the NYSE American while it attempts to regain compliance with the listing standards, subject to the Company’s compliance with other continued listing requirements. The NYSE Notice does not affect the Company’s business operations or its reporting obligations under the Securities and Exchange Commission regulations and rules.
About DayDayCook – A Leader in Food Innovation
Founded in 2012, DayDayCook is a leading content-driven consumer brand offering easy and convenient ready-to-heat, ready-to-cook and ready-to-eat Asian food products. The company focuses on innovative and healthy meal solutions with a fast-growing omnichannel sales network in China and the U.S., and through a strong online presence globally. The Company builds brand recognition through culinary and lifestyle content across major social media and e-commerce platforms.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements, including, for example, statements about completing the acquisition, anticipated revenues, growth and expansion. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. These forward-looking statements are also based on assumptions regarding the Company’s present and future business strategies and the environment in which the Company will operate in the future. Investors can find many (but not all) of these statements by the use of words such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “likely to” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.
Contact:
Investors:
CORE IR
Matt Blazei
mattb@coreir.com
Media:
CORE PR
Kati Waldenburg
pr@coreir.com
FAQ
What did DDC announce on May 21, 2024?
What is the consequence of DDC's filing delinquency?
Will DDC's shares continue to trade on NYSE American?
What sections of the NYSE American Company Guide are relevant to DDC's notice?
Why did DDC fail to file its Annual Report on time?
